Alzheimer's

A new Alzheimer's drug shown to slow progress of the disease is now being offered at both Cleveland Clinic and University Hospitals.

University Hospitals is enrolling people in a nationwide study of the effects of an experimental drug, which was recently found, in an unrelated study, to slow memory loss for those in the early stages of Alzheimer’s disease.

Researchers are launching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease.

Despite FDA approval of the brand name Aduhelm and its generic aducanumab and criticism from the Alzheimer’s Association, the Clinic says its doctors can prescribe the medications, but patients will need to get the treatments elsewhere.

A University of Cincinnati researcher, whose new study was published Monday, says a protein replacement therapy would address the cause of the disease.

Two state senators say Ohio needs to come up with a comprehensive plan to deal with rising numbers of residents with Alzheimer’s and dementia that are…

A team at Case Western Reserve University has come up with a new approach to treating Multiple Sclerosis. They’ve also launched a business to bring the…

More than five million Americans suffer from Alzheimer’s Disease.And according to the Alzheimer’s Association, that number could double in the next two…

The Alzheimer’s Association has been lobbying state lawmakers to increase awareness of the disease and lobby for more public money to fight it. Republican…